NCT06013956View on ClinicalTrials.gov

Personalized Real-Time DBS and PD Mechanisms

PHASE4RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 29, 2023

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Parkinson Disease
Interventions
DEVICE

Neurostimulation

Electrical stimulation delivered via deep brain stimulation electrodes based on measurements of brain activity.

DRUG

Carbidopa 25/Levodopa 100Mg Tab

Anti-parkinsonian medication.

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

The Cleveland Clinic

OTHER

lead

David Escobar

OTHER